STANDARD CHIN

K983754 · Surgical Technology Laboratories, Inc. · FWP · Nov 20, 1998 · General, Plastic Surgery

Device Facts

• Record ID: K983754
• Device Name: STANDARD CHIN
• Applicant: Surgical Technology Laboratories, Inc.
• Product Code: FWP · General, Plastic Surgery
• Decision Date: Nov 20, 1998
• Decision: SESE
• Submission Type: Special
• Regulation: 21 CFR 878.3550
• Device Class: Class 2
• Attributes: Therapeutic

Intended Use

Surgical Technology Laboratories, Inc. Standard Chin implants are intended to be used to augment or reconstruct the anterior of the mandible for cosmetic or reconstructive surgery.

Device Story

Standard Chin is a surgical implant designed for augmentation or reconstruction of the anterior mandible. Used by surgeons in clinical settings for cosmetic or reconstructive procedures. The device provides structural support to the chin area to achieve desired aesthetic or functional outcomes.

Technological Characteristics

Mandibular implant for chin augmentation/reconstruction. Class II device (Product Code FWP).

Indications for Use

Indicated for patients requiring augmentation or reconstruction of the anterior mandible for cosmetic or reconstructive purposes.

Regulatory Classification

Identification

A chin prosthesis is a silicone rubber solid device intended to be implanted to augment or reconstruct the chin.

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo is circular and contains the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is an abstract symbol that resembles an eagle or a stylized human figure.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

NOV 20 1998

Mr. Richard T. Nock Vice President Surgical Technology Laboratories, Inc. 1588 East 40th St. Cleveland, Ohio 44103

Re: K983754 Trade Name: Standard Chin Regulatory Class: II Product Code: FWP Dated: October 16, 1998 Received: October 22, 1998

Dear Mr. Nock:

We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition. FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.

{1}------------------------------------------------

Page 2 - Mr. Richard T. Knock

This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at [phone]. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at [phone]. Also, please note the regulation entitled, "Misbranding by reference to premarket notification"(21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number [phone] or [phone], or at its internet address "http://www.fda.gov/cdrh/dsma/dsmamain.html".

Sincerely yours,

tcollafa

Celia M. Witten, Ph.D., M.D. Director Division of General and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

Image /page/2/Picture/0 description: The image shows the logo for Surgical Technology Laboratories, Inc. The text "Surgical Technology Laboratories, Inc." is written in a bold, sans-serif font. Above the logo, the text '98-11-19 11:35 SURGIFORM' is printed in a smaller font. There is a black bar on the left side of the image.

Image /page/2/Picture/1 description: The image shows a series of bold, black numbers and letters. The characters are 'K143754'. The font is thick and stylized, making the characters appear somewhat abstract.

H. C

1588 East 40th St. Cleveland, Ohio 44103

[phone]

510(k) Number (if known): K 983754

Device Name: Standard Chin

## Indications for Use:

Surgical Technology Laboratories, Inc. Standard Chin implants are intended to be used to augment or reconstruct the anterior of the mandible for cosmetic or reconstructive surgery.

Prescription Use
(Per 21 CFR 801.109)

Acoelof

983754